Blood test for lung cancer screening in smokers and former smokers
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 50 years old (or 55–74 if joining from the ZORALCS study)
- Have smoked cigarettes or be willing to participate without smoking history (depending on study group)
- Provide a blood sample for biomarker testing
- Be available to complete study visits as scheduled
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for changes in saliva (epigenetic biomarkers) that may help doctors diagnose squamous cell carcinoma in the mouth. You may be asked for saliva samples and usual clinical checks to see whether the test can help with diagnosis, especially before surgery.
This study tests a new blood test that looks for lung cancer DNA. It may help find lung cancer early, especially in people at higher risk.
This study is testing a new blood test to help diagnose lung cancer by looking at certain markers in your DNA. Researchers want to see if this test can accurately find lung cancer, which could lead to earlier detection.
This study tests a blood test that looks for DNA changes from lung cancer. It aims to find out if the test can help tell whether a lung nodule is cancer or not, so that people might avoid unnecessary procedures.
This trial uses a simple blood test (liquid biopsy) to find tumor DNA in people suspected of having lung cancer. The goal is to learn if this test can help doctors make better treatment decisions without needing a tissue sample.
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
Hear when a new Epigenetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.